Genomic Corporation

Genomic Corporation We are a single stop for comprehensive Genetic Testing ranging from single gene to NGS panels.

Eid Mubarak from Genomics! May this special day be filled with joy, love, and blessings for you and your loved ones.www....
21/04/2023

Eid Mubarak from Genomics! May this special day be filled with joy, love, and blessings for you and your loved ones.

www.genomicscorporation.com

Join us in supporting Autism Awareness Month this April by taking action to uncover the genetic basis of ASDs. Do you kn...
03/04/2023

Join us in supporting Autism Awareness Month this April by taking action to uncover the genetic basis of ASDs.

Do you know Autism could be hereditary & has genetic basis? Genomics offers comprehensive genetic testing options, including complete Exome & genome sequencing that are WES & WGS as well as relevant panels to help children affected by autism spectrum disorders to find answers for setting up a suitable treatment methodology and take control of their health. Contact us today to learn more and take the first step in unlocking the genetic code of autistic patients.

www.genomicscorporation.com

Did you know that epilepsy can be hereditary? On Purple Day, we stand with the epilepsy community to raise awareness abo...
26/03/2023

Did you know that epilepsy can be hereditary? On Purple Day, we stand with the epilepsy community to raise awareness about this neurological disorder and the importance of early diagnosis and treatment. At Genomics, an affiliated genetic testing service of Centogene, we offer genetic testing services relevant to congenital epilepsy, including multiple panels as well as WES and WGS. By analyzing a patient's genetic makeup, we can identify underlying causes of epilepsy and help develop personalized treatment plans. Join us and Centogene in supporting the epilepsy community and advancing precision medicine through genomics.

www.genomicscorporation.com

As the holy month of Ramadan draws near, we at Genomics Corporation would like to take this opportunity to wish our Musl...
22/03/2023

As the holy month of Ramadan draws near, we at Genomics Corporation would like to take this opportunity to wish our Muslim customers and friends a blessed and fulfilling Ramadan. During this time of spiritual reflection and self-examination, understanding your genetic makeup can help you make informed decisions about your health and well-being. Our genetic testing services provide valuable insights into your risk for certain diseases, as well as guidance on personalized nutrition and fitness plans. Let us help you take charge of your health this Ramadan and beyond. Ramadan Mubarak!

www.genomicscorporation.com

Join us in raising awareness about Down syndrome and the importance of genetic testing for healthier future generations....
21/03/2023

Join us in raising awareness about Down syndrome and the importance of genetic testing for healthier future generations.

Offering Non Invasive Prenatal testing (NIPT) for screening the down syndromic fetus (Trisomy 21) during early gestational age. Also furnishing postnatal diagnostics through chromosomal microarrays in the form of CentoArray Cyto.

Share this post to spread the word and tag a friend who would benefit from our prenatal (NIPT) and postnatal (centoarray cyto) analysis for Down syndrome. Let's empower families with the knowledge they need to make informed decisions about their healthier generations.

www.genomicscorporation.com

Unlock new treatment options in oncology with our Somatic Mutational Screening services. Centogene's solid tumor panel a...
15/03/2023

Unlock new treatment options in oncology with our Somatic Mutational Screening services. Centogene's solid tumor panel and myeloid tumor panel testings can provide valuable insights relevant to therapeutics for physicians and patients alike. With a short turnaround time of just 10 working days, we're here to help improve understanding as well as to refine prognosis and therapy based on detected specific active genetic variants.
These panels are mainly recommended to the following types of patients:
• With aggressive, advanced, or metastasized forms of cancers
• Where the first line treatment has failed
• With limited treatment options or relevant side effects in standard treatment

Contact us today to learn more!

www.genomicscorporation.com

Joining hands on World Hearing Day! Nearly 20% of global population is living with deafness with a expectant of increase...
03/03/2023

Joining hands on World Hearing Day!

Nearly 20% of global population is living with deafness with a expectant of increase by 700 million people with hearing loss by 2050. In Pakistan, approximately 1.6 per 1000 persons are suffering from bilateral hearing loss and 70% raise is due to consanguineous families & is running as a hereditary defect in their generations.Today, we are celebrating the importance of hearing health and raising awareness about the impact of various hereditary hearing impairments & deafness in individuals and communities around there world.

We at Genomics are proud to partner with Centogene by offering access to their advanced genetic testing services to individuals and families in Pakistan who are suffering from rare congenital hearing loss or variable genetic disorders associated with hearing ability.One such test is CentoHear, an NGS genetic analysis that can identify potential genetic causes of hearing defects & deafness by analyzing an individual's genetic makeup.

By offering advanced genetic diagnostics, we are committed to promote hearing health and improving the lives of those families affected with congenital hearing loss or defects, thus helping them to make informed decisions for their well being of upcoming generations. Through our sample collection services, we make it convenient for people to access Centogene's innovative solutions.

On this World Hearing Day, let's work together to raise awareness about hearing health and ensure that everyone has access to the care and support they need. To learn more about our sample collection services and the genetic testing solutions we offer through our partnership with Centogene, visit our website or contact our team.

www.genomicscorporation.com

Hey everyone,Have you heard about the Centogene's BRCA 1/2 test? It's a genetic screening NGS analysis that helps identi...
01/03/2023

Hey everyone,

Have you heard about the Centogene's BRCA 1/2 test? It's a genetic screening NGS analysis that helps identify inherited mutations in the BRCA1 and BRCA2 genes, which are majorly linked to an increased risk of breast and ovarian cancer as well as prostate cancer in males too.

This test can provide valuable information to individuals and families who may be at risk for these types of cancer. It's a simple, non-invasive test that requires only a small quantity of patient's blood and results are typically available within a few weeks.

If you or someone you know has a family history of breast or ovarian cancer or even prostate cancer, or if you're just interested in learning more about your genetic health, we highly recommend checking out the Centogene BRCA 1/2 test. It could help provide important insights and potentially save lives.
Thinking about tomorrow, Today!!!

www.genomicscorporation.com

Rare Disease Day globally reserved on February, 28 is a significant chance for us to come together for raising awareness...
28/02/2023

Rare Disease Day globally reserved on February, 28 is a significant chance for us to come together for raising awareness and advocacy for the millions of people affected by congenital rare diseases worldwide.

This year, join us in acknowledging RARE DISEASE DAY and help us in spreading the word about the urgent need in continuous & advanced research in diagnostics & therapeutics of number of rare disease, and eventually support quite a lot of patients suffering from variable hereditary rare disorders.

Did you know that over 300 million people worldwide suffer from rare diseases? These conditions often go undiagnosed or even misdiagnosed, leaving patients feeling isolated and unsupported. But being united & through valuable assistance, we can at least help them in validated diagnosis so as to set a treatment line.

This Rare Disease Day, let's come together to show our support for those affected by rare diseases. By spreading awareness, we can not only help increase funding for research but also provide patients with requisite diagnostic platform for confirming their clinical suspicions, innovation in treatment lines, and thus improving the lives of millions of people & their families.

So join us in raising this awareness by sharing this post and advocating for those families with rare diseases. Together, we can make a difference & bring hope to those who need it most!!

www.genomicscorporation.com

Introducing another Centogene's product CentoNIPT, a non-invasive prenatal testing (NIPT) that can help screen for commo...
25/02/2023

Introducing another Centogene's product CentoNIPT, a non-invasive prenatal testing (NIPT) that can help screen for common chromosomal abnormalities in the developing fetus. CentoNIPT is a safe and accurate alternative to invasive prenatal testing procedures like amniocentesis & CVS being performed on maternal blood and it can be performed as early as 10 weeks of pregnancy.

By analyzing fetal DNA in mother's blood, CentoNIPT can detect chromosomal anomalies like Down syndrome, Edwards syndrome, and Patau syndrome as well as s*x chromosomal aneuploidies with a high degree of accuracy. This information can help expectant parents make more informed decisions about their pregnancy by knowing about the health of the arriving baby. Not only this, it also detects the fetal gender in early stages of pregnancy as in first trimester.

Being a screening test, it is a valuable tool for any expectant parents who intend to predict for chromosomal abnormalities in their developing fetus. It's always recommended to consult with a qualified healthcare professional or discuss the details with our team before pursuing this prenatal testing as this is not a diagnostic test yet a screening tool.

Learn more about Centogene's genetic testing products, including CentoNIPT, at our website.

www.genomicscorporation.com

Introducing Cento Cancer, an essential genetic testing product from Centogene that can help identify inherited genetic v...
22/02/2023

Introducing Cento Cancer, an essential genetic testing product from Centogene that can help identify inherited genetic variants/mutations in relevant oncogenes that increase the risk of developing certain types of cancer.

Cento Cancer is a valuable tool for individuals who are either affected with any type of carcinoma or have a personal & strong family history of any cancer, and it can provide important information to assist oncologists in making therapeutic decisions.

This cancer screening test enables in prevention and is a valuable diagnostic tool for therapeutics in patients suffering from cancers. It's important to note that cancer genetic screening can have important implications for individuals and their families, and it's always recommended to consult with a qualified healthcare professional before pursuing genetic testing.

If you or someone you know is concerned about their risk of developing certain types of cancer, Cento Cancer may be a valuable resource. Learn more about Centogene's genetic testing products at our website.

www.genomicscorporation.com

Centoxome (WES) is a cutting-edge genetic testing product developed by Centogene, a biotech company specialized in genet...
18/02/2023

Centoxome (WES) is a cutting-edge genetic testing product developed by Centogene, a biotech company specialized in genetic testing and diagnostic services. This test is designed to tackle the diagnostic challenges by utilizing advanced sequencing and bioinformatics tools to analyze an individual's whole exome (protein-coding regions). This allows to identify potentially disease-causing genetic variants that may have been missed by other diagnostic tests or can be difficult to diagnose using traditional methods.

The results of the Centoxome test are reviewed by a team of geneticists and medical experts, who provide a detailed report to the ordering physician that inturn assist the clinicians in making more informed decisions about treatment and management of rare genetic disorders.
Few examples of rare genetic disorders that could be diagnosed by Centoxome are:

Autism (ASDs), Global developmental delays, delayed milestones, growth delays.

Neurological disorders such as Huntington's disease, muscular dystrophy, and ALS

Metabolic disorders such as Gaucher disease, Fabry disease, and Niemann-Pick disease

Immunodeficiency disorders such as Severe Combined Immunodeficiency (SCID), X-Linked Agammaglobulinemia (XLA), and DiGeorge syndrome

Rare developmental disorders such as Cornelia de Lange syndrome, Kabuki syndrome, and Williams syndrome

Any congenital disorder with unpredicted etiology or unconfirmed diagnosis.

www.genomicscorporation.com

Address

Building No. 140/17 Sector C, Broadway Commercial Phase 8 DHA
Lahore

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

+923134653336

Alerts

Be the first to know and let us send you an email when Genomic Corporation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Genomic Corporation:

Share